Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DRD4 Antikörper (AA 365-391)

Der Maus Monoklonal Anti-DRD4-Antikörper wurde für WB validiert. Er ist geeignet, DRD4 in Proben von Human und Maus zu detektieren. Es sind 4+ Publikationen verfügbar.
Produktnummer ABIN1882235

Kurzübersicht für DRD4 Antikörper (AA 365-391) (ABIN1882235)

Target

Alle DRD4 Antikörper anzeigen
DRD4 (Dopamine Receptor D4 (DRD4))

Reaktivität

  • 59
  • 42
  • 14
  • 1
  • 1
  • 1
  • 1
Human, Maus

Wirt

  • 56
  • 10
Maus

Klonalität

  • 55
  • 10
Monoklonal

Konjugat

  • 28
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser DRD4 Antikörper ist unkonjugiert

Applikation

  • 51
  • 27
  • 13
  • 13
  • 10
  • 8
  • 7
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB)

Klon

625CT1-5-4
  • Bindungsspezifität

    • 15
    • 7
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 365-391

    Aufreinigung

    This antibody is purified through a protein G column, followed by dialysis against PBS.

    Immunogen

    This DRD4 antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 365-391 amino acids from the Central region of human DRD4.

    Isotyp

    IgG1
  • Applikationshinweise

    WB: 1:100~250

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Zeng, Ye, Lu, Chua, Tan, Zhong: "Chiral Brønsted acid catalyzed enantioselective addition of alpha-isocyanoacetamides to aldehydes." in: Organic letters, Vol. 12, Issue 10, pp. 2414-7, (2010) (PubMed).

    Lai, Zhu, Huo, Sun, Yu, Wang, Chai, Li: "Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction." in: Brain research, Vol. 1359, pp. 227-32, (2010) (PubMed).

    Gadow, Devincent, Olvet, Pisarevskaya, Hatchwell: "Association of DRD4 polymorphism with severity of oppositional defiant disorder, separation anxiety disorder and repetitive behaviors in children with autism spectrum disorder." in: The European journal of neuroscience, Vol. 32, Issue 6, pp. 1058-65, (2010) (PubMed).

    Chio, Drong, Riley, Gill, Slightom, Huff: "D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells." in: The Journal of biological chemistry, Vol. 269, Issue 16, pp. 11813-9, (1994) (PubMed).

  • Target

    DRD4 (Dopamine Receptor D4 (DRD4))

    Andere Bezeichnung

    DRD4

    Hintergrund

    This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats, the sequence shown contains four repeats.

    Molekulargewicht

    43901

    NCBI Accession

    NP_000788

    UniProt

    P21917

    Pathways

    cAMP Metabolic Process, Synaptic Membrane, Proton Transport, Photoperiodism, Negative Regulation of Transporter Activity
Sie sind hier:
Chat with us!